Latest Drug Interactions Impacting Older Adults: Updated 2019 Beers List by American Geriatrics Society

Medicine pills spilling out of bottle in question mark symbol

In 2019, the American Geriatrics Society (AGS) published an update to its Beers Criteria® list for Potentially Inappropriate Medication (PIM) Use in Older Adults. The guide outlines:

  • medications that are potentially inappropriate in most older adults,
  • those that should typically be avoided in older adults with certain conditions,
  • drugs to use with caution,
  • drug-drug interactions, and
  • drug dose adjustment based on kidney function.

The targeted audience for the AGS Beers Criteria® is practicing clinicians from across the care continuum (except for palliative and hospice care). It is meant to be used as an evidence-based resource to inform clinical decisions, further supporting the clinician’s judgment as well as the patient’s preferences, values, care goals, and needs, e.g. what matters to them.

In the 2019 AGS Beers Criteria® update, an interdisciplinary, continuum-based clinical expert panel identified new medications, clarified criteria language and rationale, and added selected drug‐drug interactions.

The following clinical and patient-focused resources outline the AGS Beers Criteria®, summarize the 2019 changes and provide educational tools for multiple stakeholders:

Connection to Hendrich II Fall Risk Model®

Medication use is one of the most readily modifiable fall risks. Multiple medications of any type, and psychotropic drugs in particular, are associated with an increased risk for falls. Utilization of the AGS Beers Criteria® guide supports the assessment of the appropriateness of specific drugs as well as drug-to-drug interactions that should be considered by the interprofessional care team.


2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 2019; 67: 674-694. DOI:10.1111/jgs.15767

Back to Outcomes & Aging